Do supplements actually fix low libido? A pharmacist's TikTok, examined
Quick answer
Low libido can reflect underlying hypogonadism, elevated cortisol, thyroid dysfunction, depression, or medication effects, none of which are reliably addressed by the supplement stack described in this video. Fenugreek and ashwagandha have modest RCT evidence in healthy populations, but neither is a substitute for hormonal evaluation in patients with persistent or worsening symptoms. Clinicians should ask about supplement use proactively, as patients frequently initiate these without disclosure.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @thewellnesspharm actually say?
A self-identified pharmacist on TikTok laid out four supplements she calls "natural remedies that legit work so well" for low libido: maca root, shatavari, fenugreek, and ashwagandha. She linked each to a specific mechanism, maca boosting dopamine, shatavari supporting estrogen and lubrication, fenugreek increasing testosterone, and ashwagandha lowering cortisol. She also stated plainly that "if you don't have optimal testosterone levels, you're gonna feel flat," framing suboptimal testosterone as a near-universal driver of low desire. The video has 131,600 views and is tagged under wellness tips and low libido, so a lot of people are taking notes.
Credit where it's due: she didn't sell anything in the clip itself, and she acknowledged stress as a root cause rather than just throwing pills at a symptom. That's a better starting point than most supplement content on this platform.
Does the science back this up?
Partially, but the confidence level she projects is significantly ahead of what the evidence actually supports. These are small-study supplements, not well-replicated clinical findings. Here's what the research actually shows, and where it falls apart.
Maca: The dopamine mechanism she cites is not well-established in humans. A 2010 systematic review by Shin et al. in BMC Complementary and Alternative Medicine found some evidence for maca improving self-reported sexual dysfunction, but effect sizes were small and most trials were underpowered. The dopamine framing is largely extrapolated from animal models.
Shatavari (Shatavari asparagus racemosus): The estrogen-support claim is plausible in the sense that shatavari contains phytoestrogens, but calling it something that "supports your estrogen" glosses over real complexity. It doesn't raise circulating estradiol in any well-controlled human trial. A 2018 review in the Journal of Ethnopharmacology noted adaptogenic and mucilaginous properties but stopped well short of confirming hormonal benefit in clinical populations.
Fenugreek: This is where she's on her strongest footing. A randomized controlled trial by Steels et al. (2011, Phytotherapy Research) found fenugreek extract improved sexual function scores in healthy men. A separate trial in women (Rao et al., 2015, Health) showed similar self-reported benefit. The testosterone-boosting claim is less clean, with effects modest and variable across studies.
Ashwagandha: The cortisol-lowering claim has the most consistent human data behind it. A double-blind RCT by Chandrasekhar et al. (2012, Indian Journal of Psychological Medicine) found significant cortisol reduction and improved stress scores. Whether that translates to libido specifically is less studied, but the mechanism she describes is at least grounded in something real.
What did they get wrong (or right)?
The biggest problem is the certainty. Phrases like "it definitely increases testosterone" applied to fenugreek are overselling a messy literature. The word "definitely" has no business being in a sentence about a supplement with inconsistent trial results and no regulatory approval for hormonal effects.
The dopamine mechanism for maca is the weakest link in the video. Saying maca "boosts dopamine so you actually feel desire again" is a mechanistic claim with essentially no solid human pharmacokinetic data behind it. It sounds precise. It isn't.
What she got right: the cortisol-libido connection is underappreciated and real. High cortisol suppresses gonadotropin-releasing hormone, which downstream reduces sex hormone production. Ashwagandha's cortisol data is among the more replicable findings in the adaptogen space. She also got the framing right that low libido is common and underreported. That part needed saying.
One important omission: she didn't mention that persistent low libido, especially with fatigue, mood changes, or menstrual irregularity, warrants a clinical workup before reaching for supplements. Low libido can be a symptom of hypothyroidism, hypogonadism, depression, or medication side effects. None of those are fixed by maca.
What should you actually know?
Low libido has multiple causes and supplements are, at best, one small lever. Before spending money on any of these four, a few things are worth knowing.
- Fenugreek has the strongest RCT evidence in this group, but trials are mostly short-term (6-12 weeks) and effects are modest. It's not a testosterone therapy replacement.
- Ashwagandha's cortisol data is real, but if your libido is low because of a relationship issue, a sleep disorder, or an SSRI you're taking, lowering cortisol won't fix that.
- Shatavari is safe for most people but the hormonal claims are speculative. If you have estrogen-sensitive conditions, talk to a clinician before using phytoestrogen-containing herbs.
- Maca is probably safe and might help some people subjectively. The mechanistic explanations in this video are largely borrowed from preclinical data and shouldn't be taken at face value.
- None of these supplements are FDA-approved to treat sexual dysfunction. That's not automatically disqualifying, but it means quality control, dosing consistency, and third-party testing matter more than the label claims.
If low libido is significantly affecting your life, a telehealth consultation to check testosterone, thyroid, and general hormonal panel is a more evidence-based starting point than a supplement stack built from a 60-second video.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Do supplements actually fix low libido? A pharmacist's TikTok, examined, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Do supplements actually fix low libido? A pharmacist's TikTok, examined is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Low libido can reflect underlying hypogonadism, elevated cortisol, thyroid dysfunction, depression, or medication effects, none of which are reliably addressed by the supplement stack described in this video.
FormBlends verdict
Low libido can reflect underlying hypogonadism, elevated cortisol, thyroid dysfunction, depression, or medication effects, none of which are reliably addressed by the supplement stack described in this video. Fenugreek and ashwagandha have modest RCT evidence in healthy populations, but neither is a substitute for hormonal evaluation in patients with persistent or worsening symptoms. Clinicians should ask about supplement use proactively, as patients frequently initiate these without disclosure.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Low libido can reflect underlying hypogonadism, elevated cortisol, thyroid dysfunction, depression, or medication effects, none of which are reliably addressed by the supplement stack described in this video. Fenugreek and ashwagandha have modest RCT evidence in healthy populations, but neither is a substitute for hormonal evaluation in patients with persistent or worsening symptoms. Clinicians should ask about supplement use proactively, as patients frequently initiate these without disclosure.
- Fenugreek has the most consistent human RCT data in this group: Steels et al. (2011) and Rao et al. (2015) both found modest improvements in sexual function scores, though testosterone effects were variable.
- Ashwagandha's cortisol-lowering effect is real and reproducible (Chandrasekhar et al., 2012), but it addresses only stress-driven libido suppression and won't resolve hormonal, relational, or medication-related causes.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Fenugreek has the most consistent human RCT data in this group: Steels et al. (2011) and Rao et al. (2015) both found modest improvements in sexual function scores, though testosterone effects were variable.
- Ashwagandha's cortisol-lowering effect is real and reproducible (Chandrasekhar et al., 2012), but it addresses only stress-driven libido suppression and won't resolve hormonal, relational, or medication-related causes.
- Maca's dopamine mechanism as stated in the video has no confirmed human pharmacological basis; benefit appears to be real for some individuals but the 'why' is not established science.
- Shatavari does not raise circulating estradiol in controlled human trials; its phytoestrogen content is real but the estrogen-support framing is an overstatement of available evidence.
- Persistent low libido, especially with fatigue, mood changes, or cycle irregularities, warrants a clinical evaluation for hypogonadism, thyroid dysfunction, or depression before starting any supplement regimen.
- None of these four supplements are FDA-approved for sexual dysfunction; third-party testing for purity and potency is essential since supplement labeling is not federally verified.
- Stress-related libido suppression via the cortisol-GnRH axis is a clinically recognized pathway, and the video's framing of stress as an underappreciated driver is accurate and worth taking seriously.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Ariana Medizade · TikTok creator
131.6K views on this video
You can find these in supplement form- so good for low libido #libido #pharmacist #lowlibido #wellnesstips
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Ariana Medizade, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.